Cohort of Well-differentiated Grade 3 Neuroendocrine Digestive Tumors
NCT04365023
·
clinicaltrials.gov ↗
COMPLETED
Status
168
Enrollment
OTHER
Sponsor class
Conditions
Neuroendocrine Tumors
Interventions
DRUG:
platinum chemotherapy
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
[object Object]
[object Object]